Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 281

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers

Open access
Hoste, Eric A.J., McCullough, Peter A., Kashani, Kianoush, Chawla, Lakhmir S., Joannidis, Michael, Shaw, Andrew D., Feldkamp, Thorsten, Uettwiller-Geiger, Denise L., McCarthy, Paul, Shi, Jing, Walker, Michael G., Kellum, John A.·2014·Nephrology Dialysis Transplantation

Abstract

BACKGROUND: Acute kidney injury (AKI) remains a deadly condition. Tissue inhibitor of metalloproteinases (TIMP)-2 and insulin-like growth factor binding protein (IGFBP)7 are two recently discovered urinary biomarkers for AKI. We now report on the development, and diagnostic accuracy of two clinical cutoffs for a test using these markers. METHODS: We derived cutoffs based on sensitivity and specificity for prediction of Kidney Disease: Improving Global Outcomes Stages 2-3 AKI within 12 h using data from a previously published multicenter cohort (Sapphire). Next, we verified these cutoffs in a new study (Opal) enrolling 154 critically ill adults from six sites in the USA. RESULTS: One hundred subjects (14%) in Sapphire and 27 (18%) in Opal met the primary end point. The results of the Opal study replicated those of Sapphire. Relative risk (95% CI) in both studies for subjects testing at ≤0.3 versus >0.3-2 were 4.7 (1.5-16) and 4.4 (2.5-8.7), or 12 (4.2-40) and 18 (10-37) for ≤0.3 versus >2. For the 0.3 cutoff, sensitivity was 89% in both studies, and specificity 50 and 53%. For 2.0, sensitivity was 42 and 44%, and specificity 95 and 90%. CONCLUSIONS: Urinary [TIMP-2]•[IGFBP7] values of 0.3 or greater identify patients at high risk and those >2 at highest risk for AKI and provide new information to support clinical decision-making. CLINICAL TRIALS REGISTRATION: Clintrials.gov # NCT01209169 (Sapphire) and NCT01846884 (Opal).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ndt/gfu292

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 36 references

Cited by

See all 281

Metadata

Authors
Hoste, E. A. J., McCullough, P. A., Kashani, K., Chawla, L. S., Joannidis, M., Shaw, A. D., Feldkamp, T., Uettwiller-Geiger, D. L., McCarthy, P., Shi, J., Walker, M. G., & Kellum, J. A.
Venue
Nephrology Dialysis Transplantation
Published
2014-09-18
Volume
29
Issue
11
Pages
2054-2061
ISSN
  • 0931-0509 (ISSN-L)
  • 1460-2385
OpenAlex
W2158575236
Cited by
281
References
36
FWCI
18.98
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers. https://app.cochat.ai/papers/10.1093/ndt/gfu292
The paper
Hoste, E. A. J., McCullough, P. A., Kashani, K., Chawla, L. S., Joannidis, M., Shaw, A. D., Feldkamp, T., Uettwiller-Geiger, D. L., McCarthy, P., Shi, J., Walker, M. G., & Kellum, J. A. (2014). Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfu292

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.